Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Thesalivaryalpha‑Amylaseconcentrationinpatientswithrheumatoid Arthritis:A Case–Control Study Publisher



Pakravan F1 ; Isfahani MN2 ; Ghorbani M3 ; Salesi N4 ; Salesi M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Oral and Maxillo‑facial Medicine, Dental Implants Research Center, Dental Research Institute, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Emergency Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Graduate Student, Dental Students’ Research Committee, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Student of Dentistry, Isfahan (Khorasgan) Branch of Islamic Azad University, Isfahan, Iran
  5. 5. Department of Rheumatology, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Dental Research Journal Published:2023


Abstract

Background: Rheumatoid arthritis (RA) is one of the most common chronic inflammatory diseases. Previous studies have reported an association between stress and salivary alpha‑amylase.The aim of this study was to investigate the concentration of salivary alpha‑amylase in patients with RA (by elimination of stress factor). Materials and Methods: In this case–control study, we enrolled 50 patients with RA and 48 healthy patients as the control group.The perceived stress scale questionnaire was used to evaluate scores of stress in both case and control groups, and then the participants with high scores of stress were excluded from the study. Moreover, the alpha‑amylase activity kit was used for the assessment of the levels of salivary alpha‑amylase. In all analyses, the significance level was considered to be < 0.05. Finally, the obtained data were analyzed by SPSS22. Results: Our results indicated a high score of stress in the case group (19.42 ± 5.83 units) compared with the control group (18.02 ± 6.07 units) which was not statistically significant (P < 0.248). Moreover, we demonstrated a high salivary alpha‑amylase concentration in the case group (340.65 ± 38.04 units) compared to the control group (302.62 ± 58.72 units), which was statistically significant (P < 0.001). The sensitivity and specificity of this method, at >312 alpha‑amylase concentrations, were 80% and 46%, respectively. Conclusion: In general, we indicated that the alpha‑amylase concentration in patients with RA is higher than the healthy controls, and can be used as a codiagnostic factor. © 2023 Wolters Kluwer Medknow Publications. All rights reserved.